Albany Medical Center Study Finds Accelerate Pheno System Helps Improve Sepsis and Mortality Outcomes
Apr 08, 2021
A new study published in Antimicrobial Agents and Chemotherapy found that implementing the Accelerate Pheno® system helped Albany Medical Center Hospital significantly improve laboratory workflow and multiple clinical outcomes for patients with Gram-negative bacteremia. The institution found post-implementation improvements in time to susceptibility results, antibiotic exposure, risk of 30-day mortality, and sepsis resolution.
The complete manuscript is available at this link.
The publication’s PubMed listing is at: https://pubmed.ncbi.nlm.nih.gov/33753337/
- New Accelerate Pheno® Landmark Study Validates Important Clinical Benefits to Be Presented at ECCMID 2021
Jun 30, 2021
- Accelerate Diagnostics Receives CARB-X Award to Develop Rapid Optical Imaging Technology for Sepsis and Antibiotic-Resistant Infections
Jun 08, 2021